
Photo from Timothée Olivier/X
Oct 8, 2024, 13:20
The use of surrogate endpoints in solid and haematological cancers
Ash Paul, Medical Director at EoE Specialised Commissioning Group, UK, shared a post on X:
“Bedside implications of the use of surrogate endpoints in solid and haematological cancers: implications for our reliance on PFS, DFS, ORR, MRD and more.”
Authors: Timothée Olivier, Alyson Haslam, Dagney Ochoa, Eduardo Fernandez and Vinay Prasad.
Source: Ash Paul/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 09:00
Feb 21, 2025, 08:19
Feb 21, 2025, 06:20
Feb 20, 2025, 11:19
Feb 20, 2025, 11:13
Feb 20, 2025, 11:08